133 related articles for article (PubMed ID: 36208248)
1. [Correlation between Serum Free Light Chain and Blood Routine Parameters in Patients with Multiple Myeloma].
Li D; Jiang N; Wang JQ; Wang ZB; He Y; Zhang J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1446-1452. PubMed ID: 36208248
[TBL] [Abstract][Full Text] [Related]
2. [Clinical Significance of Serum Free Light Chain and Its κ/λ Ratio in Patients with Multiple Myeloma].
Zhao D; Jiang JQ; Lin L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1173-1178. PubMed ID: 31418375
[TBL] [Abstract][Full Text] [Related]
3. [Assessment of serum free light chain of patients with multiple myeloma and clinical significance thereof].
Sui WW; Yao HJ; Wang YF; Wang L; Zhang K; Xu Y; Qiu LG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3158-60. PubMed ID: 18269880
[TBL] [Abstract][Full Text] [Related]
4. [Effect of Serum Free Light Chain on Renal Function and Prognosis in Patients with Newly Diagnosed Multiple Myeloma].
Chen XD; Luo XF; Zu YP; Ye H; Li LL; Chen QL; Xie WZ; Yang T; Hu JD; Wei LX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1862-1868. PubMed ID: 31839051
[TBL] [Abstract][Full Text] [Related]
5. [Test of Serum Free Light Chain and Its Clinical Significance in Light Chain Multiple Myeloma].
Song P; An ZM; Zhou XG; Li F; Wang LP; Zhao Q; Yu YP; Zhai YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1357-61. PubMed ID: 26524037
[TBL] [Abstract][Full Text] [Related]
6. The association of serum-free light-chain levels with markers of renal function.
Erdem BK; Davran F; Yilmaz VT; Çetinkaya R; Akbas H
Ren Fail; 2015 Jul; 37(6):1057-60. PubMed ID: 26056734
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of serum free light chain in patients with multiple myeloma].
Zhang SS; Wu S; Qu XY; Xu J; Liu P; Lu H; Wu HX; Xu JR; Li JY; Chen LJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):930-5. PubMed ID: 23998588
[TBL] [Abstract][Full Text] [Related]
8. [The Expression Level and Diagnostic Value of Serum Free Light Chain in B-Cell Non-Hodgkin Lymphoma].
Wang Y; Wang H; Zhang JF; Li JY; Zhang NH; Wang R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1701-1705. PubMed ID: 38071048
[TBL] [Abstract][Full Text] [Related]
9. The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease.
Molina-Andújar A; Robles P; Cibeira MT; Montagud-Marrahi E; Guillen E; Xipell M; Blasco M; Poch E; Rosiñol L; Bladé J; Quintana LF
BMC Nephrol; 2020 Mar; 21(1):111. PubMed ID: 32234026
[TBL] [Abstract][Full Text] [Related]
10. [Detection of serum free light chain and its clinical significance in nonsecretory multiple myeloma].
Chen HF; Hou J; Yuan ZG; Wang DX; Fu WJ; Chen YB
Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):113-6. PubMed ID: 18681313
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients.
García de Veas Silva JL; Bermudo Guitarte C; Menéndez Valladares P; Rojas Noboa JC; Kestler K; Duro Millán R
PLoS One; 2016; 11(11):e0166841. PubMed ID: 27893836
[TBL] [Abstract][Full Text] [Related]
12. Defining the impact of individual sample variability on routine immunoassay of serum free light chains (sFLC) in multiple myeloma.
Murng SH; Follows L; Whitfield P; Snowden JA; Swallow K; Green K; Sargur R; Egner W
Clin Exp Immunol; 2013 Feb; 171(2):201-9. PubMed ID: 23286947
[TBL] [Abstract][Full Text] [Related]
13. [Clinical Significance of Serum Free Light Chain in Monoclonal Gammopathy].
Lu H; Zhang W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):155-158. PubMed ID: 38387914
[TBL] [Abstract][Full Text] [Related]
14. Clinical usefulness of serum free light chains measurement in patients with multiple myeloma: comparative analysis of two different tests.
Kubicki T; Dytfeld D; Baszczuk A; Wysocka E; Komarnicki M; Lewandowski K
Postepy Hig Med Dosw (Online); 2017 Jan; 71(0):40-46. PubMed ID: 28181910
[TBL] [Abstract][Full Text] [Related]
15. Method Comparison and Workflow Differences Using the Same Free Light Chain Assay on 2 Analyzer Platforms.
Omosule CL; Hock KG; Dalton C; Scalpati A; Gronowski AM; Brants A; Farnsworth CW
J Appl Lab Med; 2023 Jul; 8(4):689-699. PubMed ID: 37186660
[TBL] [Abstract][Full Text] [Related]
16. [The prognostic value of baseline serum free light chain in immunoglobulin light-chain cardiac amyloidosis].
Wang LM; Wang TT; Tian Y; Zhao L; Yang XC; Chen WM
Zhonghua Xue Ye Xue Za Zhi; 2020 Jan; 41(1):47-53. PubMed ID: 32023754
[No Abstract] [Full Text] [Related]
17. Polymethylmethacrylate membrane and serum free light chain removal: enhancing adsorption properties.
Fabbrini P; Sirtori S; Casiraghi E; Pieruzzi F; Genovesi S; Corti D; Brivio R; Gregorini G; Como G; Carati ML; Viganò MR; Stella A
Blood Purif; 2013; 35 Suppl 2():52-8. PubMed ID: 23676837
[TBL] [Abstract][Full Text] [Related]
18. Further stratification of patients with multiple myeloma by International Staging System in combination with ratio of serum free κ to λ light chains.
Xu Y; Sui W; Deng S; An G; Wang Y; Xie Z; Yao H; Zhu G; Zou D; Qi J; Hao M; Zhao Y; Wang J; Chen T; Qiu L
Leuk Lymphoma; 2013 Jan; 54(1):123-32. PubMed ID: 22712834
[TBL] [Abstract][Full Text] [Related]
19. [Clinical Significance of sFLC/MP Level and Light Chain Escape in Patients with Multiple Myeloma Relapse].
Xiang X; Chai Y; Wang X; Ma CC; Wang Y; Li YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Dec; 29(6):1837-1844. PubMed ID: 34893120
[TBL] [Abstract][Full Text] [Related]
20. [The roles of serum free light chain ratio in the diagnosis and prognosis of newly diagnosed multiple myeloma].
Wang PF; Xu Y; Yan S; Yao Y; Zheng HF; Ma L; Jin S; Xu Y; Gong FR; Zhou JZ; Chang HR; Fu CC
Zhonghua Xue Ye Xue Za Zhi; 2016 May; 37(5):377-82. PubMed ID: 27210871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
